Logo_AIHTA
  • Deutsch
  • Contact
    • Imprint
      • Privacy Notice
        • Newsletter
          • Sitemap
            Menu_button
            • News
              • About us
                • Research areas
                  • Research Projects
                    • Publications
                      • Search
                        • Announcements
                          • Events
                            • Newsletter
                              • Press release on our reports
                                • Press photos
                                  Video
                                  Video: What is HTA?    
                                  • Home
                                  • News

                                  News

                                  Leiste32


                                  Welcome to the homepage of AIHTA!

                                  AIHTA is an academic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                  In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                  Subscribe to newsletter

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: EU-Strukturreform Projekt zu Patient*innen-Zugang zu Medikamenten in Österreich
                                  • Angemessene Versorgung durch evidenzbasierte politische Hebel unterstützen
                                  • Robotergestützte Bewegungstherapie bei inkompletter Querschnittslähmung
                                  • Biomarker bei Alzheimer-Krankheit
                                  • Bildgesteuerte Injektionen bei chronischen Rückenschmerzen
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Umweltfolgenabschätzung als Teil von Health Technology Assessment
                                  • Wirksamkeit und Sicherheit roboterassistierter Chirurgie in der Thorax- und Viszeralchirurgie
                                  • Evoke™-System zur Rückenmarkstimulation bei chronischen Schmerzen
                                  • Instrumente zur Kategorisierung von Patient*innen während der Palliativversorgung
                                  • CT-Koronarangiografie zur Diagnose von koronarer Herzkrankheit
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Adobestock-603904097-von-tinashe-npeopleimages-com
                                  ©stock.adobe.com

                                  Announcement

                                  Economic Dimensions of Community Nursing: A Systematic Literature Review

                                  Community Nursing is a new model of care in Austria to strengthen the health of the elderly population. The literature review examines the cost-effectiveness of the concept and methods for presenting it. The results are inconclusive. The use of community nursing tends not to be cost-effective in the eleven identified studies, but methodological limitations may have biased the results. The studies are also older and largely not from Europe. Further research using more recent methodological findings from research on complex interventions and evaluation of public health interventions is needed.

                                  Publication: HTA Project Report No. 153: https://eprints.aihta.at/1470/
                                  Contact: Ingrid Zechmeister-Koss

                                   

                                  More...

                                  2183
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce you eight new Fact Sheets.

                                  Fact Sheet No. 138 (August 2023) 
                                  Crisantaspase (Enrylaze®) for the treatment of acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma (LBL)

                                  Fact Sheet No. 139 (August 2023) 
                                  Cedazuridine/decitabine (Inaqovi®) for the treatment of newly diagnosed acute myeloid leukaemia (AML)

                                  Fact Sheet No. 140 (August 2023) 
                                  Elacestrant (Orserdu®) monotherapy for the treatment of oestrogen receptor (ER)?positive, HER2-negative, locally advanced or metastatic breast cancer

                                  Fact Sheet No. 141 (August 2023) 
                                  Talquetamab (Talvey®) for the treatment of adult patients with relapsed and refractory multiple myeloma (MM)

                                  Fact Sheet No. 142 (August 2023) 
                                  Epcoritamab (Tepkinly®) as monotherapy for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

                                  Fact Sheet No. 143 (August 2023) 
                                  Tislelizumab (Tevimbra®) as monotherapy for the treatment of unresectable, locally advanced, or metastatic oesophageal squamous cell carcinoma (OSCC)

                                  Fact Sheet No. 144 (August 2023) 
                                  Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of Stage IIB or IIC melanoma, or melanoma with involvement of lymph nodes or metastatic disease

                                  Fact Sheet No. 145 (August 2023) 
                                  Pembrolizumab (Keytruda®) with trastuzumab, fluoropyrimidine and platinum-containing chemotherapy for the first-line treatment of locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction (GEJ) adenocarcinoma

                                  More...

                                  Fotolia-76406533-von-sudok1-21
                                  ©stock.adobe.com

                                  Announcement

                                  Robot-assisted surgery in thoracic and visceral indications – Update 2023

                                  Robotic-assisted surgery represents a technically advanced form of a minimally invasive procedure that claims to improve clinical outcomes as well as healthcare resource utilization. This report is an update of a systematic review from 2019, which examined the effectiveness and safety of robotic-assisted surgery in thoracic and visceral indications, compared to open surgery and conventional laparoscopy. In total, 14 indications were investigated, with no evidence identified for five indications. Due to the heterogeneous results and lack of evidence for some study endpoints, a general statement on the effectiveness and safety of robotic-assisted surgery is not possible.

                                  Publication: HTA Project Report No. 108: https://eprints.aihta.at/1461
                                  Contact : Nicole Grössmann-Waniek

                                   

                                  More...

                                  2182
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce you three new Fact Sheets.

                                  Fact Sheet No. 135 (July 2023) 
                                  Tremelimumab (Imjudo®) with durvalumab (Imfinzi®) and platinum-based chemotherapy for the first-line treatment of metastatic non-small cell lung cancer (NSCLC)

                                  Fact Sheet No. 136 (July 2023)  
                                  Trifluridine / tipiracil (Lonsurf®, TAS-02) with bevacizumab for the treatment of metastatic colorectal cancer (CRC)

                                  Fact Sheet No. 137 (July 2023) 
                                  Sacituzumab govitecan (Trodelvy®) for the treatment of unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer

                                   

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: DEGAM Leitlinie Schutz vor Über- und Unterversorgung
                                  • Bleomycin-Elektrosklerotherapie bei vaskulären Anomalien
                                  • Elektrische aurikuläre Vagusnervstimulation bei Schmerzen
                                  • 177Lu-PSMA Radioligandentherapie bei metastasiertem kastrationsresistentem Prostatakrebs
                                  • Transkranielle Magnetresonanz-gesteuerte hochintensive fokussierte Ultraschallbehandlung (tcMRgFUS) bei essentiellem Tremor
                                  • Allogene mesenchymale Stammzellen bei Morbus Crohn-assoziierten, komplexen, perianalen Fisteln
                                  • Perkutane Aspirationsthrombektomie bei Lungenembolie
                                  • Perkutane Mitralklappenintervention mittels Mitraclip bei Mitralklappeninsuffizienz
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  2427
                                  ©stock.adobe.com

                                  Announcement

                                  Evaluation of individual medical procedures - Reports 2023

                                  We are pleased to introduce our new reports.

                                  Decision Support Documents 2023:

                                  • DSD 135: Percutaneous aspiration thrombectomy for pulmonary embolism https://eprints.aihta.at/1454/
                                  • DSD 136: Transcranial magnetic resonance-guided high-intensity focused ultrasound treatment in patients with drug-resistant essential tremor https://eprints.aihta.at/1455/
                                  • DSD 137: Bleomycin Electrosclerotherapy for Vascular Anomalies: Systematic Review https://eprints.aihta.at/1456/
                                  • DSD 138: Electrical auricular vagus nerve stimulation for pain https://eprints.aihta.at/1457/

                                  + 3 Updates

                                  • DSD 41: Percutaneous mitral valve repair with a clip device in patients with mitral regurgitation. 2nd Update 2023 https://eprints.aihta.at/1451/
                                  • DSD 111: Allogeneic mesenchymal stem cells for Crohn's Disease-associated complex perianal fistulas. 1st Update 2023 https://eprints.aihta.at/1452/
                                  • DSD 118: 177Lu-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Systematic Review. 1st Update 2023 https://eprints.aihta.at/1453/

                                  More...

                                  2181
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce you three new Fact Sheets.

                                  Fact Sheet No. 130 (May 2023)
                                  Glofitamab (Columvi®) as monotherapy for the treatment of relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

                                  Fact Sheet No. 131 (May 2023)
                                  Pirtobrutinib (JaypircaTM) as monotherapy for the treatment of relapsed or refractory (R/R) mantle cell lymphoma (MCL)

                                  Fact Sheet No. 132 (May 2023)
                                  Futibatinib (Lytgobi®) for the treatment of locally advanced or metastatic cholangiocarcinoma

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Erkrankungen mit ungedecktem (Forschungs- und Versorgungs-) Bedarf trotz hoher Krankheitslast
                                  • H.E.L.P.-Apherese und Hyperbare Sauerstofftherapie als individuelle Gesundheitsleistung zur Behandlung von Long-/Post-COVID
                                  • Therapien bei Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom (ME/CFS)
                                  • Lecanemab zur Therapie von Alzheimer-Demenz
                                  • Medikamentenbeschichteter Ballondilatationskatheter (Optilume) zur transurethralen Behandlung von Harnröhrenstrikturen
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  « < ... 4 5 6 7 8 ... > »
                                  Displaying results 51 to 60.
                                  • News
                                    • Announcements
                                      • Events
                                        • Newsletter
                                          • Press release on our reports
                                            • Press photos
                                            • About us
                                              • Evaluation
                                                • History
                                                  • Methods
                                                    • Team
                                                      • Shareholder & organization chart
                                                        • Stakeholder involvement
                                                          • Press clippings
                                                          • Research areas
                                                            • Oncology
                                                              • High tech medicine
                                                                • Rehabilitation and occupational therapy
                                                                  • Prevention and screening
                                                                    • Psychological & psychiatric interventions
                                                                      • Health economics
                                                                        • European collaboration
                                                                          • HTA-methods & steering instruments
                                                                            • Complementary medicine
                                                                            • Research Projects
                                                                              • Synopsis of current research projects
                                                                                • Synopsis of completed research projects
                                                                                  • Decision Support Documents for the Austrian Appraisal Board
                                                                                    • HTA-Information Service Rapid Reviews
                                                                                      • Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
                                                                                        • Horizon Scanning of Medicines - Reports and Fact Sheets
                                                                                          • Horizon Scanning in Oncology – support for a budget-impact-calculation
                                                                                            • Evaluation of individual medical procedures - Reports
                                                                                              • All projects in an overview
                                                                                              • Publications
                                                                                                • Repository
                                                                                                  • HTA-Newsletter
                                                                                                    • Annual Reports
                                                                                                    • Search
                                                                                                      Netzwerk
                                                                                                      • Eunethta
                                                                                                      • Ebm
                                                                                                      • Inahta
                                                                                                      • Dexhelpp
                                                                                                      Shareholder
                                                                                                      • Bmfg
                                                                                                      • Sv
                                                                                                      • Wgfond
                                                                                                      • Noe
                                                                                                      • Ooghfond
                                                                                                      • Ghls
                                                                                                      • Tirol
                                                                                                      • Vorarlberg
                                                                                                      • Kghfond
                                                                                                      • Ghpf
                                                                                                      • Burgef
                                                                                                      • Contact
                                                                                                        • Imprint
                                                                                                          • Privacy Notice
                                                                                                            • Newsletter
                                                                                                              • Sitemap
                                                                                                                © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                • Log in